文献速递甲状腺疾病

先天性甲状腺功能减退症中非经典剪接位点变异对RNA剪接的影响

Insights of Noncanonical Splice-site Variants on RNA Splicing in Patients With Congenital Hypothyroidism.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

研究分析47个家系55例先天性甲状腺功能减退症(CH)患者的二代测序数据,用微小基因RNA剪接实验评估内含子非经典剪接位点变异。发现SLC26A4和SLC5A5的2个新深内含子突变导致外显子跳跃,使本队列病因检出率约45%;已报道的28个非经典剪接位点变异中约54%导致异常剪接,CADD预测准确性最高(81%)。

要点

  • CH患者中非经典剪接位点变异需功能实验验证致病性。
  • SLC26A4 c.1707+94C>T和SLC5A5 c.970-48G>C分别导致外显子15/16和8跳跃。
  • CADD对非经典剪接位点变异预测准确性优于FATHMM-XF和FATHMM-MKL。

核心结论

  • 在SLC26A4和SLC5A5中发现两个新的深内含子突变,使本队列病因检出率约45%。
  • 已报道的非经典剪接位点变异中约46%(13/28)不破坏pre-mRNA剪接。
  • CADD对非经典剪接位点变异的预测准确性最高。

研究设计与样本

  • 分析47个家系55例CH患者的二代测序数据以识别罕见内含子变异。
  • 用微小基因RNA剪接实验研究变异对pre-mRNA剪接的影响。
  • 比较3种变异预测程序(FATHMM-XF、FATHMM-MKL、CADD)对32个变异的预测准确性。

主要发现

  • 3例患者中检出4个内含子变异:SLC26A4 c.1544+9C>T和c.1707+94C>T(1例),SLC5A5 c.970-48G>C和c.1652-97A>C(2例)。
  • c.1707+94C>T导致外显子15和16跳跃,c.970-48G>C导致外显子8跳跃,其余变异对RNA剪接无影响。
  • 28个已报道非经典剪接位点变异中15个(约54%)导致异常剪接,13个对RNA剪接无影响。
  • 32个变异中FATHMM-XF、FATHMM-MKL和CADD分别正确预测20个(63%)、17个(53%)和26个(81%)。

关键数值与推荐

  • 非经典剪接位点变异致病性需通过RNA剪接实验确认。
  • CADD预测非经典剪接位点变异准确性最高(81%)。

临床怎么用

  • 对CH患者检出的非经典剪接位点变异应进行功能验证以明确致病性。
  • CADD可作为非经典剪接位点变异预测的优先工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Congenital hypothyroidism (CH) is caused by mutations in the genes for thyroid hormone synthesis. In our previous investigation of CH patients, approximately 53% of patients had mutations in either coding exons or canonical splice sites of causative genes. Noncanonical splice-site variants in the intron were detected but their pathogenic significance was not known. OBJECTIVE: This work aims to evaluate noncanonical splice-site variants on pre-messenger RNA (pre-mRNA) splicing of CH-causing genes. METHODS: Next-generation sequencing data of 55 CH cases in 47 families were analyzed to identify rare intron variants. The effects of variants on pre-mRNA splicing were investigated by minigene RNA-splicing assay. RESULTS: Four intron variants were found in 3 patients: solute carrier family 26 member 4 (SLC26A4) c.1544+9C>T and c.1707+94C>T in one patient, and solute carrier family 5 member 5 (SLC5A5) c.970-48G>C and c.1652-97A>C in 2 other patients. The c.1707+94C>T and c.970-48G>C caused exons 15 and 16 skipping, and exon 8 skipping, respectively. The remaining variants had no effect on RNA splicing. Furthermore, we analyzed 28 previously reported noncanonical splice-site variants (4 in TG and 24 in SLC26A4). Among them, 15 variants (~ 54%) resulted in aberrant splicing and 13 variants had no effect on RNA splicing. These data were compared with 3 variant-prediction programs (FATHMM-XF, FATHMM-MKL, and CADD). Among 32 variants, FATHMM-XF, FATHMM-MKL, and CADD correctly predicted 20 (63%), 17 (53%), and 26 (81%) variants, respectively. CONCLUSION: Two novel deep intron mutations have been identified in SLC26A4 and SLC5A5, bringing the total number of solved families with disease-causing mutations to approximately 45% in our cohort. Approximately 46% (13/28) of reported noncanonical splice-site mutations do not disrupt pre-mRNA splicing. CADD provides highest prediction accuracy of noncanonical splice-site variants.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Albader N, Zou M, BinEssa HA, et al. Insights of Noncanonical Splice-site Variants on RNA Splicing in Patients With Congenital Hypothyroidism. J Clin Endocrinol Metab. 2022. PMID: 34632506. doi:10.1210/clinem/dgab737

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。